Claims
- 1. A composition that enhances lymphoblastic proliferation of a mixed leukocyte population, comprising a lymphoblastic proliferation enhancing amount of a hemolytic anemia-related factor (HMF) and red blood cells, in association with a carrier, wherein said HMF comprises the amino acid sequence as defined in SEQ ID NO:4.
- 2. The composition of claim 1, wherein said HMF is a fusion protein.
- 3. The composition of claim 2, wherein said fusion protein is a HMF-GST fusion.
- 4. A method for enhancing the lymphoblastic proliferation in a mixed leukocyte population, which comprises incubating said leukocyte population with lymphoblastic proliferation enhancing amount of hemolytic anemia related factor, HMF, comprising the amino acid sequence as defined in SEQ ID NO:4.
- 5. The method of claim 4, wherein red blood cells are incubated with said leukocyte population and said HMF and wherein said red blood cells further potentiate said lymphoblastic proliferation.
- 6. The method of claim 4, wherein said enhancement of lymphoblastic proliferation is observed after 3 days of incubation of said mixed leukocyte population with said HMF.
- 7. The method of claim 4, wherein said HMF is a fusion protein.
- 8. The method of claim 7, wherein said fusion protein is a HMF-GST fusion.
Parent Case Info
This application is a continuation-in-part of the application which Ser. No. is 08/546,872 filed on Oct. 23, 1995.
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
546872 |
Oct 1995 |
|